09 October 2007

Obagi - Clenziderm


Penetrating Acne
Therapeutic Systems
Introducing Obagi CLENZIderm M.D.™ Systems — the only prescription-strength, physician dispensed acne systems with a patent-pending 5% liquified benzoyl peroxide.

CLENZIderm M.D.™ Systems are clinically proven to better penetrate the follicles for effective P. acnes bacteria reduction and rapid lesion reduction.*

CLENZIderm M.D. now offers the exclusive SoluZyl technology in two systems - one for Normal to Oily Skin (Serum Gel) and one for Normal to Dry Skin (Therapeutic Lotion).

THE SCIENCE BEHIND CLENZIDERM M.D.™
CLENZIderm M.D.™ offers two different three product systems that have the only liquified form of 5% benzoyl peroxide solubilized to 1/10,000 the size of any other benzoyl peroxide on the market for deeper follicular penetration.
Most benzoyl peroxides are formulated with insoluble crystals that, when applied, remain largely on the surface of the skin because they are too big to penetrate the follicle.
CLENZIderm M.D.™ Systems utilize patent-pending SoluZyl™ Technology in which benzoyl peroxide is in a liquified form. As a result, CLENZIderm M.D.™ delivers more benzoyl peroxide deep into the follicle — for better results!

* Postered at the 2007 Annual American Academy of Dematology Meeting. Click here to view the full study.
Comparison chart
The chart below illustrates the size of the average benzoyl peroxide particle, the size of the benzoyl peroxide in CLENZIderm M.D.™ and the size of a hair follicle.
  • Benzoyl peroxide crystals
    (insoluble, irregular shapes and sizes) range from 0.01-0.1 mm
  • Average follicle size is 0.05 mm
CLENZIderm M.D.™ benzoyl peroxide is 10-7 mm
  • Homogeneous solution for better
    follicular penetration

No comments: